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Abstract 
Depth of invasion is an important predictor of survival. A study by the International Consortium (ICOR) for 
Outcome Research proposed incorporation of it (together with the greatest surface dimension, or the anatomical 
criteria, or both) into the T stage. This has been adopted in part by the 8th edition of the Union for International 
Cancer Control (UICC) TNM 8 classification of malignant tumours for oral squamous cell carcinoma (SCC). Our aim 
was to verify depth of invasion as an independent prognostic factor, and to validate the staging by comparing it 
with that specified in the 7th edition (TNM 7) and the T-staging model proposed by the International Consortium. 
We retrospectively studied 449 patients who had had operations for a previously untreated primary oral cancer 
between 2006 and 2014 at a single centre, and analysed the independent predictive value of depth of invasion for 
both disease-specific and overall survival. It was an independent predictor of disease-specific survival as were sex, 
perineural invasion, and N stage. It was also an independent predictor of overall survival together with sex and N 
status. Staging in TNM 8 gave a better balance of distribution than that in TNM 7, but did not discriminate 
between prognosis in patients with T3 and T4 disease. The proposed International Consortium rules for T-staging 
gave an improved balance in distribution and hazard discrimination. The incorporation of depth of invasion into 
the T-staging rules for oral SCC improved prognostic accuracy and is likely to influence the selection of patients for 
adjuvant treatment. Our findings suggest that the TNM 8 staging lacks hazard discrimination in patients with 
locally-advanced disease because its T4 staging is restricted to anatomical criteria. 
 
Introduction 
TNM staging for cancer was first developed and published by Pierre Denoix in 1952,1 and the first edition of the 
Union Internationale Contre le Cancer (UICC) TNM Classification of Malignant Tumours was published in 1953.2 
The American Joint Committee on Cancer (AJCC), which was established in 1959, published the first cancer staging 
manual in 1977.3 Close cooperation between these organisations enabled the development of a universal system 
for the classification of tumours of epithelial origin. 
 
Tumour thickness or depth of invasion, or both, have been reported to be objective predictors of nodal 
involvement and survival,4 and proposed modifications of the T staging of oral squamous cell carcinoma (SCC) 
incorporate depth of invasion.5,6 
 
In 2014, the International Consortium (ICOR) for Outcome Research in head and neck cancer investigated the 
predictive value of depth of invasion.7 This retrospective multicentre study of 3149 patients from 11 
 “ĐŽŵƉƌĞŚĞŶƐŝǀĞĐĂŶĐĞƌĐĞŶƚƌĞƐ ?ǁŽƌůĚwide showed that depth of invasion was predictive of disease-specific 
survival. Based on this, a new model was proposed (Table 1) that incorporated depth of invasion into the T-
staging criteria. It was also incorporated into the 8th edition of the UICC T staging of oral SCC (TNM 8),8 which is 
similar to that proposed by the ICOR, but T4 staging is restricted to anatomical criteria. 
 
Our aim was to verify depth of invasion as an independent prognostic factor, and to validate staging in the 8th 
edition (TNM 8) by comparing it with that specified in the 7th edition (TNM 7) and the T-staging model proposed 
by the ICOR. 
 
Methods 
We retrospectively studied 467 previously untreated patients with oral SCC, who were treated with curative 
intent by operation, with or without adjuvant treatment, between 2006 and 2014 (inclusive) at our hospital. We 
excluded 18 (4%) because of insufficient information on depth of invasion, so the final group comprised 449 
patients. Primary tumours were excised with a macroscopic margin of 1 cm based on clinical examination and 
cross-sectional imaging, and patients were followed up for a minimum of 24 months. Clinical and pathological 
data points were retrieved from case records. 
 
Tables 2A and 2B show the clinicopathological variables. We used the definitive histopathology report on the 
resected specimen to allocate pathological T stages according to TNM 7, TNM 8, and ICOR criteria. Tumour less 
than 1 mm from a resection margin was considered involved; tumour 1 ?5 mm from the closest margin, close. 
Histopathology 
Moore et al9 described the depth of invasion as the distance from the epithelial basal membrane to the deepest 
point of infiltration. We reconstructed the epithelial surface if it was ulcerated or the tumour was exophytic. 
Pathologists who had a subspecialty interest in diseases of the head and neck did the histological evaluation. 
 
Statistical analysis 
 
Statistical analysis was done with the help of SPSS Statistics for Windows version 22.0 (IBM Corp). The clinical end 
points of interest were overall survival and disease-specific survival. Survival time was calculated from the date of 
operation. A significance level of 5% was used for all statistical analyses. For continuous variables (depth of 
invasion, age) univariate analysis was done by comparison of means using the t test or Mann-Whitney U test as 
appropriate (Fig. 1B). For categorical variables, including T stage, Kaplan-Meier survival curves were constructed 
and the significance calculated with the log-rank test (Cox-Mantel). All clinicopathological factors that were 
predictive of survival (including depth of invasion) on univariate analysis were entered into a Cox regression 
ŵŽĚĞůƚŽĞƐƚĂďůŝƐŚŝŶĚĞƉĞŶĚĞŶƚƉƌĞĚŝĐƚŽƌƐŽĨƐƵƌǀŝǀĂů ?dĂďůĞ ? ? ?Žǆ ?ƐƉƌŽƉŽƌƚŝŽŶĂůŚĂǌĂƌĚƌĞŐƌĞƐƐŝŽŶǁĂƐƵƐĞĚƚŽ
calculate the separation between the survival curves in each system with the T4 category as the comparator. The 
T staging systems were also evaluated using the о2 log likelihood test for fit of the data. 
 
Results 
There were 180 women and 269 men (ratio 1:1.5) with a median (range) age of 62 (22 ?94) years. Median (range) 
follow up was 51(2 ?60) months. The distribution of patients in each T category according to TNM 7, TNM 8, and 
the proposed ICOR criteria, is shown in Table 2A. TNM 7 rules resulted in a comparatively poor distribution 
balance across the T categories with a paucity of patients in T3 (n = 14). 
Specimens showed perineural invasion (n = 107, 24%), lymphovascular invasion (n = 105, 23%), and extranodal 
extension (n = 93, 21%). A total of 33 patients (7%) had involved margins. N stages are shown in Table 2A. These 
were pathological (pN) if patients had had lymphadenectomy when the primary tumour was resected. 
 
The mean (range) depth of invasion was 8.16 (0.3-40)mm. On univariate analysis (Table 2B) it was a predictor(p < 
0.0001) of both disease-specific and overall survival. On multivariate analysis it was an independent predictor of 
disease-specific survival, as were sex, perineural invasion, and regional lymph node metastases. It was an 
independent predictor of overall survival together with sex and pathological nodal involvement (Table 3). Disease 
specific survival curves for the three staging systems are shown in Fig. 1 and the overall survival curves in Fig. 2.  
 
Both show comparatively poor hazard discrimination between T3 and T4 groups for ďŽƚŚdED ?ĂŶĚ ?ƌƵůĞƐ ?Žǆ ?Ɛ
regression analysis (Table 4)showed that only the ICOR T-staging rules could discriminate between the prognosis 
for patients with T3 primary tumours and those with T4 disease. Goodness-of-fit tests showed that TNM 8 
improved performance more than TNM 7, but was inferior to the ICOR staging system (Table 4). 
 
Discussion 
 
Accurate staging is key to the management of oral SCC, as it informs treatment and provides important 
information that can help clinicians, patients, and their families understand the probability of a cure. The status of 
the regional lymph nodes is the most important determinant of outcome and strongly influences the 
recommendation for adjuvant treatment after primary operation, but T staging has not consistently been 
independently prognostic.10 It is possible that its relatively low discriminatory value is, at least partly, a 
consequence of the staging rules applied. 
 
This has been recognised in the latest (8th) edition of the UICC TNM staging manual. Two key changes have 
been made. One is the omission of an anatomical criterion (which has caused much vexed discussion in 
multidisciplinary team meetings), specifically the allocation of T4 status based on involvement of deep extrinsic 
muscles of the tongue. However, it is not clear what this means or whether it indicates advanced disease or an 
accident of anatomy. A tumour in the midline floor of the mouth has to invade only a few millimetres before it 
penetrates the oral surface of genioglossus. Similarly, a tumour on the posterolateral tongue may invade the 
styloglossus, palatoglossus, or hyoglossus, as soon as it penetrates much beyond the submucosa. These 
accidents of anatomy do not inform our understanding of tumour biology, and this problem has almost certainly 
resulted in too many patients being staged as T4, which has devalued its use for staging of the primary site. 
TNM 8 has continued to use only anatomical rules for the allocation of T4, which might explain its inferior 
performance in hazard discrimination compared with the proposed model by the ICOR (Figs. 1 and 2). 
 
Involvement of the skin might also be an accident of anatomy. Any tumour that is deeper than 5 ?6 mm and arises 
on the buccal mucosa close to the oral commissure is likely to involve skin, but we have been unable to find 
evidence that this in itself carries an adverse prognosis. Similarly, oral SCC that arises on the gum will invade the 
mandible relatively early. We speculate that the stipulation in the ICOR model that T4 status requires a depth of 
invasion of 10 mm or more, overcomes this potential weakness. 
 
Our findings that depth of invasion is an independent predictor of both disease-specific and overall survival 
further validate the recognition of its importance in the 8th edition. It has resulted in a more balanced allocation 
to the T categories and greater prognostic accuracy. Recent trial data show that clinical teams have already 
realised that a 10 mm depthofinvasionisanindicationforadjuvantradiotherapy.11  The allocation of T3 status to 
patients with oral SCC that was previously staged as T1 or T2, will broaden that practice and improve the balance 
in the distribution between T categories. There are, however, difficulties. Histopathological assessment of depth 
of invasion is subjective and the interobserver error is unknown. Depth of invasion is also a continuous variable 
that will probably be associated with a continuum of risk (albeit non-linear), so the dichotomous categorisation at 
5mm and 10mm12 will probably be challenged. Nevertheless, our findings support those of the much larger study 
by the ICOR.7      
 
Optimal staging rules should meet three criteria: hazard consistency (same survival rate within each stage when 
applied to different groups of patients), hazard discrimination (different survival rates among groups), and 
balance in distribution (enough patients in each group to predict survival (statistical strength)).13 The survival 
curves for the different T staging systems (Figs. 1 and 2) show that TNM 8 offers a better balance in distribution 
than TNM 7. However, the TNM 8 rules in this group did not separate the survival curves for the T3 and T4 
categories, possibly for the reasons outlined above, and they therefore lack hazard discrimination. This 
contradicts the findings in the two-centre validation group13 that suggested that TNM 8 might lack hazard 
consistency. In contrast, we found that the proposed ICOR staging system showed good balance in distribution 
and good hazard discrimination. 
 
In conclusion, application of the staging rules in TNM 8 and those of the ICOR resulted in a better balance in the 
distribution of patients across the T stages than application of those in TNM 7. However, only the ICOR rules gave 
adequate hazard discrimination in this group, which suggests that accurate staging of T4 requires consideration of 
depth of invasion as well as anatomical features. This finding now requires confirmation in larger retrospective 
and prospective studies. 
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Table 1 
 
Criteria of the different staging systems. 
 
Staging System 
 
A. International Consortium: 
T1 UICC 7th T1 or less in greatest dimension, maximum depth of invasion <5 mm 
T2 UICC 7th T1, maximum depth of invasion ш5 mm 
T3 UICC 7th T2, maximum depth of invasion ш10mm 
T4 UICC 7th T3-T4, maximum depth of invasion ш10mm 
 
B. 8th edition UICC (TNM8) 
T1 2 cm or less in greatest dimension, maximum depth of invasion DOI <5 mm 
T2 2 cm or less in greatest dimension, maximum depth of invasion ш5 mm, or tumour >2 cm and 4 cm or more 
in greatest dimension, maximum depth of invasion<10 mm 
T3 Any tumour maximum depth of invasion ш10 mm or tumour >4 cm in greatest dimension 
T4a Invades through cortical bone, or maxillary sinus, or invades skin 
T4b Invades masticator space, pterygoid plates or skull base, or encases the internal carotid artery 
 
C. 7th edition UICC (TNM7) 
T1 2 cm or less in greatest dimension 
T2 Tumour >2 cm and 4 cm or more in greatest dimension  
T3 Tumour >4 cm in greatest dimension 
T4a Invades bone, or maxillary sinus, or invades skin, into deep extrinsic muscles of the tongue 
T4b Invades masticator space, pterygoid plates or skull base, or encases the internal carotid artery 
 
 
  
Table 2A 
Descriptive and univariate analysis of the categorical data. 
 No. (%)  Disease-specific survival  Overall 
survival 
Clinicopathological 
variables: Sex:  
 
0.015 0.009 
Female   180 (40)   
Male   269 (60)   
pT category  7th edition UICC (TNM 7):   <0.0001 <0.0001 
T1   200 (45)   
T2   111 (25)   
T3   14 (3)   
T4   124 (27)   
pT category  8th edition UICC (TNM 8):   <0.0001 <0.0001 
T1   143 (32)   
T2   136 (30)   
T3   99 (22)   
T4   71 (16)   
pT category  International Consortium:   <0.0001 <0.0001 
T1   142 (32)   
T2   130 (29)   
T3   82 (18)   
T4   95 (21)   
Pathological  N category:   <0.0001 <0.0001 
N0   282 (63)   
N1   53 (12)   
N2   113 (25)   
N3   1 (0.2)   
Lymphovascular invasion:   <0.0001 <0.0001 
Present  105 (23)   
Absent  344 (77)   
Perineural invasion:   <0.0001 <0.0001 
Present  107 (24)   
Absent  342 (76)   
Extranodal extension:   <0.0001 <0.0001 
Present  93 (79)   
Absent  356 (21)   
Margins:   0.825 0.348 
Involved  33 (7)   
Close  233 (52)   
Clear  183 (41)   
Adjuvant treatment: 
Radiotherapy  97 (22) 
  
Neoadjuvant chemotherapy  15 (3)   
Concurrent chemoradiotherapy  86 (19)   
  
Table 2B 
Continuous clinicopathological variables 
 
 
  
 Mean (SD)  No.  p value 
Age (years): 
Alive  60.72(11.7)  309  0.082 
Died any cause  62.76 (10.9)  140  
Alive  61.37 (11.6)  364  0.947 
Died of disease  61.28 (11.06)  85  
Depth of invasion (mm): 
Alive  6.52(5.12)  309  <0.0001 
Died any cause  11.78 (8.37)  140  
Alive  6.9 (5.7)  364  <0.0001 
Died of disease  13.54 (8.32)  85  
Table 3 
Independent predictors of survival. 
Variable B (SE) Wald Statistic  p value  Exp(B) (95% CI) 
Overall survival: 
Sex  0.383  (0.186)  4.213  0.040  1.47 (1.017 to 2.113) 
Depth of invasion  0.068  (0.010)  43.541  <0.0001  1.07 (1.049 to 1.092) 
N stage  0.478  (0.095)  25.076  <0.0001  1.61 (1.338 to 1.945) 
Disease-specific survival: 
Sex  0.519  (0.246)  4.441  0.035  1.681 (1.037  to  2.724) 
Depth of invasion  0.073  (0.013)  32.766  <0.0001  1.075 (1.049  to  1.102) 
Perineural invasion  0.556  (0.231)  5.792  0.016  1.744 (1.109  to  2.744) 
N stage  0.709  (0.132)  29.062  <0.0001  2.032 (1.570  to  2.629) 
Table 4 
Cox proportional hazard regression of the Kaplan Meier curves in each staging system. (baseline T4), 
and о2 log likelihood goodness-of-fit testing of the different staging systems. 
 TNM 7  TNM 8  ICOR 
Žǆ ?ƐƌĞŐƌĞƐƐŝŽŶ ? 
Disease-specific 
survival: 
T4 - T1  p < 0.0001  p < 0.0001  p < 0.0001 
T4 - T2  p = 0.009  p < 0.0001  p < 0.0001 
T4 - T3  p = 0.332  p = 0.701  p = 0.009 
Overall survival: 
T4 - T1  p < 0.0001  p < 0.0001  p < 0.0001 
T4 - T2 p = 0.002  p < 0.0001  p < 0.0001 
T4 - T3  p = 0.390  p = 0.758  p = 0.001 
Goodness of fit of the different staging systems: 
Disease-specific survival 964.007 951.683  946.452 
Overall survival  1605.68  1593.729  1584.867 
ICOR: International Consortium for Outcome Research. 
  
  
 
Figure 1. Disease-specific survival calculated with Kaplan Meier curves (A = TNM 7; B = TNM 8; C = 
International Consortium staging; D = presence of the examined criteria in each staging system: 
hazard discrimination and balance in distribution; E = five-year survival according to TNM 7, TNM 8, 
and ICOR staging). 
  
 
 
 
Figure 2. Overall survival calculated with Kaplan Meier curves (A = TNM 7; B = TNM 8; C = 
International Consortium staging; D = presence of the examined criteria in each staging system: 
hazard discrimination and balance in distribution; E = five-year survival according to TNM 7, TNM 
8, and ICOR staging). 
 
